Transition to Routine Premedication for Nonemergent Intubations in a Level IV Neonatal Intensive Care Unit

Am J Perinatol. 2018 Mar;35(4):336-344. doi: 10.1055/s-0037-1607282. Epub 2017 Oct 11.

Abstract

Objective: This study aims to test whether implementing a guideline for nonemergent intubation improves the rate of premedication for nonemergent intubations in an academic level IV neonatal intensive care unit (NICU). We further sought to test the hypothesis that neonates who receive premedication for a nonemergent intubation have decreased pain scores at the time of intubation, fewer intubation attempts, and no associated adverse events.

Study design: This was a prospective observational study with ongoing audit and feedback as well as statistical process control analysis. Data collection began on October 1, 2014. Clinical guideline implementation began in October 2015. A percent "P"-chart spanning seven-quarters was constructed with statistical process control analysis plotting premedication rates over time. Student's t-tests or Wilcoxon rank-sum tests were used for secondary outcomes.

Results: The mean number of nonemergent intubations given premedications increased from 34 to 82%. The mean pain score was lower when premedications were given: 0.34 (95% confidence interval [CI]: 0.10-0.58) versus 2.8 (95% CI: 1.9-3.6) (p < 0.001). The number of intubation attempts did not differ with premedications.

Conclusion: Adopting a guideline with supporting educational initiatives to standardize premedication before nonemergent intubations increased this practice. This regimen lowered clinical pain scores with no difference in the number of intubation attempts.

Publication types

  • Observational Study

MeSH terms

  • Analgesics, Opioid / therapeutic use
  • Female
  • Humans
  • Infant, Newborn
  • Intensive Care, Neonatal / standards*
  • Intubation, Intratracheal / adverse effects*
  • Male
  • Pain / etiology
  • Pain / prevention & control*
  • Practice Guidelines as Topic
  • Premedication / statistics & numerical data*
  • Prospective Studies
  • Quality Improvement / organization & administration

Substances

  • Analgesics, Opioid